Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Search by expertise, name or affiliation
Prot# CYC682-06-05 (A2): A Randomized Phase II Study of Oral Sapacitabine in Patients with Advanced Cutaneous T-Cell Lymphoma
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
10/7/08
→
10/7/11
Funding
Cyclacel Pharmaceuticals, Inc.
(CYC682-06-05 (A2))
View all
View less